1. Design, Synthesis and Structure-Activity Relationship Study of Wollamide B; a New Potential Anti TB Agent. Asfaw, H., K. Laqua, A.M. Walkowska, F. Cunningham, M.S. Martinez-Martinez, J.C. Cuevas-Zurita, L. Ballell-Pages, and P. Imming. Plos One, 2017. 12(4): p. e0176088. PMID[28423019]. PMCID[PMC5397059].
[PubMed]. TB_04_2017.
2. Design, Synthesis and Biological Evaluation of Novel Tetrahydroquinoline Based Propanehydrazides as Antitubercular Agents. Chander, S., P. Ashok, B.D. Maira, P. Cos, D. Cappoen, and S. Murugesan. Letters in Drug Design & Discovery, 2017. 14(3): p. 293-300. ISI[000395675400006].
[WOS]. TB_04_2017.
3. Novel Bacterial Topoisomerase Inhibitors with Potent Broad-spectrum Activity against Drug-resistant Bacteria. Charrier, C., A.M. Salisbury, V.J. Savage, T. Duffy, E. Moyo, N. Chaffer-Malam, N. Ooi, R. Newman, J. Cheung, R. Metzger, D. McGarry, M. Pichowicz, R. Sigerson, I.R. Cooper, G. Nelson, H.S. Butler, M. Craighead, A.J. Ratcliffe, S.A. Best, and N.R. Stokes. Antimicrobial Agents and Chemotherapy, 2017. 61(5): e02100-16. PMID[28223393].
[PubMed]. TB_04_2017.
4. Ga(III) Nanoparticles Inhibit Growth of Both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages. Choi, S.R., B.E. Britigan, and P. Narayanasamy. Antimicrobial Agents and Chemotherapy, 2017. 61(4): e02505-16. PMID[28167548]. PMCID[PMC5365726].
[PubMed]. TB_04_2017.
5. Design, Synthesis, Molecular-docking and Antimycobacterial Evaluation of Some Novel 1,2,3-Triazolyl xanthenones. Goud, G.L., S. Ramesh, D. Ashok, V.P. Reddy, P. Yogeeswari, D. Sriram, B. Saikrishna, and V. Manga. MedChemComm, 2017. 8(3): p. 559-570. ISI[000398533700007].
[WOS]. TB_04_2017.
6. Synthesis and Antibacterial Activity of 3-Benzylamide Derivatives as FtsZ Inhibitors. Hu, Z., S. Zhang, W. Zhou, X. Ma, and G. Xiang. Bioorganic & Medicinal Chemistry Letters, 2017. 27(8): p. 1854-1858. PMID[28285910].
[PubMed]. TB_04_2017.
7. Synthesis of Readily Available Fluorophenylalanine Derivatives and Investigation of Their Biological Activity. Kratky, M., S. Stepankova, K. Vorcakova, L. Navratilova, F. Trejtnar, J. Stolarikova, and J. Vinsova. Bioorganic Chemistry, 2017. 71: p. 244-256. PMID[28245905].
[PubMed]. TB_04_2017.
8. Functional, Thermodynamics, Structural and Biological Studies of in Silico-identified Inhibitors of Mycobacterium tuberculosis Enoyl-ACP(CoA) Reductase Enzyme. Martinelli, L.K.B., M. Rotta, A.D. Villela, V.S. Rodrigues-Junior, B.L. Abbadi, R.V. Trindade, G.O. Petersen, G.M. Danesi, L.R. Nery, I. Pauli, M.M. Campos, C.D. Bonan, O.N. de Souza, L.A. Basso, and D.S. Santos. Scientific Reports, 2017. 7(46696): 15pp. PMID[28436453]. PMCID[PMC5402281].
[PubMed]. TB_04_2017.
9. Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome. Moreira, W., S. Santhanakrishnan, G.J.Y. Ngan, C.B. Low, K. Sangthongpitag, A. Poulsen, B.W. Dymock, and T. Dick. Antimicrobial Agents and Chemotherapy, 2017. 61(5): e02307-16. PMID[28193668].
[PubMed]. TB_04_2017.
10. Antibacterial Activities of Chemical Constituents from the Aerial Parts of Hedyotis pilulifera. Nguyen, H.T., D.V. Ho, H.Q. Vo, A.T. Le, H.M. Nguyen, T. Kodama, T. Ito, H. Morita, and A. Raal. Pharmaceutical Biology, 2017. 55(1): p. 787-791. PMID[28103726].
[PubMed]. TB_04_2017.
11. In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China. Pang, Y., H. Zheng, Y. Tan, Y. Song, and Y. Zhao. Antimicrobial Agents and Chemotherapy, 2017. 61(5): e02627-16. PMID[28242674].
[PubMed]. TB_04_2017.
12. Novel Chemical Scaffolds for Inhibition of Rifamycin-resistant RNA Polymerase Discovered from High-throughput Screening. Scharf, N.T., V. Molodtsov, A. Kontos, K.S. Murakami, and G.A. Garcia. SLAS Discovery, 2017. 22(3): p. 287-297. PMID[28027449]. PMCID[PMC5323270].
[PubMed]. TB_04_2017.
13. Synthesis of New Pyrido-benzodiazepine salts and Their Antimicrobial Activities. Seebacher, W., F. Belaj, J. Faist, R. Saf, F. Bucar, I. Turek, A. Brantner, M. Alajlani, M. Kaiser, P. Maser, and R. Weis. Monatshefte fur Chemie, 2017. 148(2): p. 263-274. ISI[000396527800010].
[WOS]. TB_04_2017.
14. Design, Synthesis and Biological Evaluation of New Substituted Sulfonamide Tetrazole Derivatives as Antitubercular Agents. Suresh, A., N. Suresh, S. Misra, M.M.K. Kumar, and K. Sekhar. ChemistrySelect, 2016. 1(8): p. 1705-1710. ISI[000395407100030].
[WOS]. TB_04_2017.
15. Design, Synthesis, and Experimental Validation of Peptide Ligands Targeting Mycobacterium tuberculosis Sigma Factors. Vishwanath, S., S. Banerjee, A.K. Jamithireddy, N. Srinivasan, B. Gopal, and J. Chatterjee. Biochemistry, 2017. 56(16): p. 2209-2218. PMID[28355052].
[PubMed]. TB_04_2017.
Patent Citations
16. Oxazolidinone Compounds and Methods of Use Thereof as Antibacterial Agents. Mandal, M.B., D.B. Olsen, J. Su, L. Yang, K. Young, T. Suzuki, and L. You. Patent. 2017. 2016-US57257 2017070024: 87pp.
[Patent]. TB_04_2017.
17. Combination Antibacterial Composition and Short-course Antibacterial Regimen. Mdluli, K., Jr., C.M. Mendel, and E. Nuermberger. Patent. 2017. 2016-US55414 2017066053: 36pp.
[Patent]. TB_04_2017.
18. Inhibitors of Sulfur Metabolism with Potent Bactericidal Activity against MDR and XDR M. tuberculosis. Palde, P.B. and K.S. Carroll. Patent. 2017. 2016-US56228 2017069960: 43pp.
[Patent]. TB_04_2017.
19. Oxazolidinone Compounds and Methods of Use Thereof as Antibacterial Agents. Yang, L., D.B. Olsen, K. Young, J. Su, M.B. Mandal, T. Suzuki, and L. You. Patent. 2017. 2015-CN92563 2017066964: 85pp.
[Patent]. TB_04_2017.